Table 1. Relationship between LAPTM4B genotypes and clinicopathological features of HCC.

Variables	Patients	LAPTM4B genetype			Pa
		*1/1	*1/2	*2/2
Gender					0.172
Male	57	16	32	9
Female	11	6	3	2
Age (years)					0.415
<65	44	14	21	9
≥65	24	8	14	2
Viral status					0.171
Hepatitis virus B	49	16	22	11
Hepatitis virus C	12	3	9	0
Both hepatitis virus B and C	2	0	2	0
Non-B, Non-C	5	3	2	0
Tumor size					0.852
<5 cm	37	13	18	6
≥5 cm	31	9	17	5
portal vein invasion					0.001
No	49	22	22	5
Yes	19	0	13	6
Histopathological differentiation					0.009
WD	20	12	6	2
MD	25	8	14	3
PD	23	2	15	6
Serum AFP level					0.144
<25 ng/ml	35	14	18	3
≥25 ng/ml	33	8	17	8
TNM stage					<0.001
I–II	23	18	4	1
III–IV	45	4	31	10
Recurrence					<0.001
No	17	12	5	0
Yes	51	10	30	11

LAPTM4B, Lysosomal protein transmembrane 4 beta; HCC, hepatocellular carcinoma; a, Chi-square test.